Brandon Ingram Injury Status – Pelicans vs. Warriors Injury Report November 22Igor Shesterkin Reportedly Signs Historic Contract Extension With Rangers
Jessica Ennis-Hill shares top tips on how to fit in exercise around the workdayTHOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen AMGN today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Liverpool manager Arne Slot gestures on the touchline Liverpool head coach Arne Slot was far from happy with his side’s performance in the 1-0 victory at Girona which extended the Champions League leaders’ perfect start to six matches. Mohamed Salah’s 63rd-minute penalty – his 50th goal in the competition – was the difference but it was far from plain sailing with the first half particularly disturbing for Slot. “If you ask me about all the six games, I’m really pleased with all the results,” he said. “I’m really pleased with the five games, the way we played. I am far from pleased about the performance tonight.” Asked what had made him so unhappy he added: “A lot. Especially two things. “If you play against a team who has such a good idea about football and know how to bring the ball out from the back like some other teams we faced recently, like (Manchester) City or Real Madrid then you have to be so intense if you want to make it difficult for them. “But if every time you are waiting a few seconds and then if you do press, you are so easily out-played as this team can cause you problems and this is what they showed during the whole Champions League campaign, except for PSV Eindhoven away. “I almost feel sorry for them because they deserve so much more in this campaign than the three points they have now. “And every time we lost the ball we were not aggressive enough, almost every time they just went all the way to our goal. “We had hardly any control in the game, maybe the second half was better – I’m trying to be positive.” The low intensity meant goalkeeper Alisson Becker had a busier night than he would have expected after returning from two months out with a hamstring injury. He made five saves in the first half to help extend the club’s run without conceding for close to nine hours and Slot was indebted to the Brazil international. “We have an incredible goalkeeper. I said as a joke, maybe the players wanted to see how fit he was to give him so much work,” he added. “He showed today he is probably one of the best – in my opinion the best goalkeeper – in the world. “Let’s hope he can continue to keep bringing these performances and hope more he can stay fit.”How to grow a goldfish plant – the ideal conditions, according to houseplant pros
THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE AmgenPINAL COUNTY, Ariz. — The first human cases of avian flu have been reported in Arizona, according to the Arizona Department of Health Services. In a news release, AZDHS said both people who contracted avian flu were exposed to infected poultry while working at a commercial facility in Pinal County. The two people have already been treated and recovered. The news release states they both reported mild symptoms. "Most human infections with H5 virus have occurred after unprotected exposure to sick or dead infected animals or their environment," the AZDHS news release said. "Human infections with H5 can happen when the virus gets in a person’s eyes, nose, mouth or is inhaled from close or prolonged exposure to sick animals or their environments." The Arizona Department of Agriculture said earlier in November that a poultry farm in Pinal County was put under quarantine after the poultry began displaying signs of avian flu. The farm was subjected to biosecurity measures and steps were being taken to eliminate the virus. There was also avian flu detected in a backyard flock in Maricopa County, according to the news release. According to the news release, there can be anywhere from mild to extreme symptoms people with avian flu can experience, including but not limited to: upper respiratory symptoms conjunctivitis pneumonia multi-organ failure death The state is "working with local, state, and federal partners to monitor bird flu in farm animals and people who work closely with poultry and dairy cows," the news release said. The state is also giving protective gear to farm workers who have contact with infected animals, as well as making sure people exposed or who contract bird flu have access to testing and treatment. Avian influenza H5 is a novel influenza A virus that primarily affects birds, the news release said. Human infection is considered rare. To reduce the risk of infection, AZDHS said people should avoid unprotected contact with sick or dead animals and their feces or bedding, and should not consume raw dairy products. Avian flu detections have been reported in California, Oregon and Utah over the last couple of weeks, according to the Centers for Disease Control and Prevention. Watch 12News+ for free You can now watch 12News content anytime, anywhere thanks to the 12News+ app! The free 12News+ app from 12News lets users stream live events — including daily newscasts like "Today in AZ" and "12 News" and our daily lifestyle program, "Arizona Midday"—on Roku and Amazon Fire TV . 12News+ showcases live video throughout the day for breaking news, local news, weather and even an occasional moment of Zen showcasing breathtaking sights from across Arizona. Users can also watch on-demand videos of top stories, local politics, I-Team investigations, Arizona-specific features and vintage videos from the 12News archives. Roku: Add the channel from the Roku store or by searching for "12 News KPNX." Amazon Fire TV: Search for "12 News KPNX" to find the free 12News+ app to add to your account , or have the 12News+ app delivered directly to your Amazon Fire TV through Amazon.com or the Amazon app. Up to Speed Catch up on the latest news and stories on the 12News YouTube channel. Subscribe today.THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen
With technical prowess and considerable style, Marta danced around two sliding defenders, outwitted a goalkeeper and calmly scored as another player rushed forward in desperation to stop her. It was more Marta Magic. That goal last weekend helped propel the Orlando Pride into Saturday's National Women's Soccer League championship game against the Washington Spirit. Barbra Banda also scored in the Pride's 3-2 semifinal victory over the Kansas City Current . While Banda has had an incredible first season with the Pride, captain Marta has been the talisman that has helped lead the team in its remarkable turnaround this year. The last time the Pride were in the NWSL playoffs was in 2017 — Marta's first year with the club. But this season they nearly went undefeated, going 23 games without a loss to start the season before losing 2-0 to the Portland Thorns with just two regular-season games left. “I think because of the way that we did it, during this season, from beginning to now, it’s something very special that I’ve never had before with any other club that I’ve played for," Marta said. "Plus year by year, we see in America, strong competition. This is the best league in the world. And you never know what’s going to happen, and it’s hard to keep winning the games, being in the first place almost like the whole season. That’s why it’s really different and so special.” Marta’s goal was the latest gasp-inducing moment in a stellar career filled with them. Known by just her first name, the 38-year-old is a six-time FIFA world player of the year. "Let's see if tomorrow I can do something similar — or even better," Marta said on Friday. Her teammate Kylie Strom chimed in: “That was the greatest goal I've ever witnessed, hands down." Appropriate. Earlier this year, FIFA announced that the best goal in women's soccer each year would earn the Marta Award. In a lighthearted moment the day before the title match, Marta was asked if she thought it was possible she might give the award to herself. “You guys need to decide, because who votes for the best goal in the year? It’s you. It’s the people in the public. So it should be really interesting, like Marta’s Award goes to Marta!” she said with a laugh. Marta has played in six World Cups for Brazil and played this summer in her sixth Olympics, winning a silver medal after falling in the final to the United States . She previously said this would be her final year with the national team. But since then Brazil was named the host of the 2027 Women's World Cup. "I had a conversation with my coach, the national team coach, and I was really clear about playing in 2027. I told him it’s not my goal anymore,” she said. “But I’m always available to help the national team. And if they think I still can do something during this preparation for the World Cup, yeah, I would be happy to help them." Marta's club career started in Brazil when she was just 16. She has also played in Sweden and in the U.S. professional women's leagues that came before the NWSL. With nine regular-season goals, Marta has had one of her best seasons since she joined the Pride. “I can never pick a side, I never pick favorites — but I love to see this for Marta," U.S. coach Emma Hayes said. “Marta is someone we all like, admire and are grateful for. And that goal was just like prime Marta at her best. And so grateful for and thankful for her that she got the opportunity with another game with her team.” The Pride went 18-2-6 this season, clinching the NWSL Shield for the first trophy in club history. Orlando also set a record with 60 regular-season points to finish atop the standings. “We are sitting top of the table, but I think there still are a lot of doubters. I think there’s people out there who say, maybe this was a one-off season,” Strom said. “But we’re here to prove them all wrong. So I think we do carry a bit of that underdog mentality still with us.” The second-seeded Spirit advanced to the title match at Kansas City's CPKC Stadium last weekend on a penalty shootout after a 1-1 draw against defending champions Gotham FC. The Spirit's roster includes Trinity Rodman, a standout forward who formed the so-called “Triple Espresso” trio with Mallory Swanson and Sophia Smith for the United States at the Olympics. AP soccer: https://apnews.com/hub/soccer
Trump aims to appoint son-in-law’s father as US ambassador to FranceWE all love a good bargain bargain buy, so it's no surprise fashion fans obsess over some of the slashed prices in retailers like TK Maxx. The shop is known for selling brand-name and designer clothing at discounted prices. Advertisement 4 The skirt had a subtle problem with the pockets Credit: Instagram / stylingwithkenzie 4 The stitching on a pair of fluffy boots wasn't up to scratch Credit: Instagram / stylingwithkenzie 4 The stylist found a shirt with uneven front pockets Credit: Instagram / stylingwithkenzie But a fashion stylist recently noticed a problem with some of the clothes on the rails and urged shoppers to think twice before picking clothes up there. Kenzie Welch took to Instagram and explained that despite her love of the budget-friendly retailer she can't un-see one major probloem. "Ever since I noticed this one thing I can never look at their clothing the same," she explained. The issue? Some of the cloths in the shop aren't quite up to scratch and have some subtle design flaws. Advertisement READ MORE ON FASHION GAME CHANGERS Top 5 Xmas gifts for football fans from a unique experience to novelty items To prove her point, Kenzie picked up a trendy silver midi skirt which looked perfectly fine at first glance. But when she turned it around the show the back of the garment she pointed out that the back pockets were unevenly spaced out, which could make it fit weird on your bum, she said. And it wasn't just the one skirt that had this subtle design problem all of the silver skirts on the rail did too. The problem continued with a cable knit jumper, which also looked totally fine at first. Advertisement Most read in Fabulous CREAM DREAM ‘Obsessed’ cry Primark fans as they spot viral jumper in snow colour for winter XMAS SPIRIT I run a Christmas market stall, people are stunned by my queue-worthy prices DEALS ON WHEELS Exact date SHEIN Christmas bus arrives in Scotland packed with freebies WOAH BABY I’m pregnant with my step-brother’s baby – people say it’s ‘gross’ But, unlike the rest of the same jumpers on the rail, one of them was missing a design feature on the top of the sleeve, which might seem like a small problem but could completely change the way the garment fits and looks. Elsewhere in the shop, a plaid shacket also fell victim to the same issue. ‘Obsessed’ cry Primark fans as they spot viral jumper in snowy colour for winter Kenzie explained: "Here on this shacket you can see the pockets are misaligned, so this one is slightly higher on the left "It's not the most obvious thing you would notice but I can't walk into a TK Maxx anymore and not notice these small details." Advertisement And if you thought the problem wouldn't continue into the show section - you'd be wrong. Kenzie also found a pair of UGG boot dupes which had been stitched up wrong, leaving some of the inside panelling of the shoe visible. Unlike the skirt, it seemed like the problem was only on one pair of the shoes though. "Make sure you are inspecting your clothing at TK Maxx," she added. Advertisement After sharing her video on social media people were left divided over the issue. One commented on the clip: "That's literally why they're at TK Maxx." A second agreed: "That's why a lot of these items end up at TK Maxx, many of them are seconds, meaning they had slaws when created so ended up in discount shops." But others thanked Kenzie for pointing the issue out. Advertisement "This is great intel , thank you," one said. "That's fascinating! Such great tips to look out for, I had no idea," another fashion fan wrote. Read more on the Scottish Sun DARR-ARGH! Weather maps reveal exact date Storm Darragh to hit Scots with rain, wind & SNOW 'SICK BEYOND BELIEF' Cops probe footage 'showing Scots woman having sex with XL Bully dog' And someone else added: "I've noticed this and have to remind myself to slow down and be more mindful when shopping! "Stop and inspect the quality of things!" Advertisement 4 Kenzie pointed out the design flaws on the clothes Credit: Alamy How Does TK Maxx Flog Designer for Cheap? TK Maxx follows an off-price business model to get designer products for cheap It buys merchandise from various brands and designers at a discount and then sells it to customers at lower prices than traditional retail stores The selection at its outlets often includes overstocked items, last season's styles and goods from cancelled orders. The Gold Label is a premium collection of designer and luxury products offered by TK Maxx. If you love designer clothes, this is the tag you want to look out for on pieces.
We Now Have The Worst Excuse For Kamala’s Crushing LossWhile the rest of the Notre Dame community figures out whether it’s worth paying four figures for a ticket to the College Football Playoff first-round home game against Indiana, the men’s basketball team continues to figure out how to survive without Markus Burton. Notre Dame (5-5) hosts its next-to-last nonconference game Wednesday night against Dartmouth (4-4), which plays its sixth contest of a seven-game road trip. The Fighting Irish took a promising step — and snapped a five-game losing streak — on Saturday by edging Syracuse 69-64 in their ACC opener. “We needed to be in a close game and we needed to win a close game so our guys can build some belief back,” head coach Micah Shrewsberry said. “We can’t take any steps back on Wednesday.” Without Burton — the stat sheet-stuffing sophomore point guard who injured the medial collateral ligament in his knee Nov. 26 against Rutgers — the Irish are struggling to find someone to run the offense, as evidenced by their seven assists versus 15 turnovers against Syracuse. At the same time, players are filling the scoring void. Braeden Shrewsberry poured in a career-high-tying 25 points versus the Orange while hitting 6 of 11 3-point attempts. Tae Davis averaged 12.4 points and 7.2 shots per game when Burton was healthy, but he has upped his mean production to 16.6 points and 12.2 shots in the past five games. Micah Shrewsberry, though, prefers to measure progress on a possession-by-possession basis. “Just the toughness,” he said. “There have been times when we haven’t gotten the key stop. We haven’t gotten the bucket when we quite need it. It gets deflating sometimes.” Dartmouth knows that feeling. On Sunday, the Big Green took a one-point lead with 4:03 left in overtime at Illinois-Chicago — and then failed to score on their final six possessions to suffer a 69-68 loss. The Big Green, who haven’t posted a winning season since 1998-99, believe in launching 3-pointers as they take 48% of their shots from behind the arc. Senior Cade Haskins (13.6 ppg) has hit a team-high 28 of 68 3-pointers this season, though fellow senior Ryan Cornish stacks up as the team’s top scorer (14.3 ppg), passer (3.0 assists per game) and defender (2.3 steals per game). In its only previous game against a power-conference opponent, Dartmouth upset Boston College 88-83 on Nov. 29.
Trying to fit in routines around work can be tricky, especially for women. New research from Vitality’s ‘Active women, healthy lives’ report finds that eight in 10 women under 50 say their demanding work schedules are holding them back from being active. As a result, a quarter of women exercise less than once a week (25%), and over half of women exercise less than they used to (52%). Dame Jessica Ennis-Hill, in partnership with Vitality, is launching Walk Out to Work Out, a new initiative encouraging women to reclaim time during their busy working days to stay active. Jessica Ennis-Hill has shared a few tips to help women fit in exercise around their working day (Image: Vitality) Additionally, she has shared some top tips on how to fit some exercise in during the working day. The full ‘Active women, healthy lives’ report can be found on the website here . Jessica shared: "As a busy mum and business owner, I know how challenging it can be to fit in long workouts. That’s why I swear by short bursts of activity—what I call "exercise snacks." "Whether it’s a 5-minute stretch between meetings or a quick walk to clear your mind, these small moments can really add up and keep you feeling active without disrupting your day. Jessica explained: "When I need to take calls or brainstorm ideas, I often head out for a walk with my dog while doing it – ticking off two things I have to do. I find it not only helps me stay active but also boosts my creativity and focus. "Turn phone calls or virtual meetings into walking meetings where possible. It’s a simple way to add movement while staying productive." (function (d, s, n) { var js, fjs = d.getElementsByTagName(s)[0]; js = d.createElement(s); js.className = n; js.src = "//player.ex.co/player/7fa31446-b44b-41d8-91c4-a5b8b174fe05"; fjs.parentNode.insertBefore(js, fjs); js.setAttribute('programmatic', 'true'); js.onload = function () { const playerApi233613 = ExCoPlayer.connect('7fa31446-b44b-41d8-91c4-a5b8b174fe05'); playerApi233613.init({ "autoPlay": false, "mute": true, "showAds": true, "playbackMode": "play-in-view", "content": { "playFirst": [ { "title": "How much water should you drink daily?", "src": "https://large-cdn.ex.co/transformations/production/41f11a67-8a1f-4249-8ae7-12b95862b6e3/720p.mp4" } ], "playlistId": "649d736679e0a90012b5d7a8" }, "sticky": { "mode": "persistent", "closeButton": true, "pauseOnClose": true, "desktop": { "enabled": false, "position": "bottom-right" }, "mobile": { "enabled": false, "position": "upper-small" } }}); }; }(document, 'script', 'exco-player')); "As someone who’s juggled intense schedules, I’ve learned the importance of protecting my lunch break," Jessica said. "I use part of it for physical activity, whether it’s a quick workout, a jog, or a calming walk. "If you feel like your lunch break has disappeared into your workday, speak to your employer about how you can reclaim that time — it’s yours to use for your well-being. I suggest putting it in the diary as a meeting – this will ring-fence the time for you." Jessica explained: "I have worked with a lot of different sponsors and their teams and I’ve seen the difference it makes when workplaces support physical activity. "If you’re struggling to stay active, don’t hesitate to share your thoughts with your employer. Suggest ideas like walking meetings, group exercise activities, or even flexible working hours to make staying active more achievable. "Remember, these changes benefit everyone, from employees to the company itself. Recommended reading: Jessica said: "I rely on technology to keep me on track. Fitness trackers or simple alarms can remind you to stand, stretch, or take a short walk every hour. "Even small movements like this can make a huge difference to your energy levels and focus throughout the day."
More Than 1 in 5 Renters Use Their Entire Paycheck to Pay Rent: SurveyBy RONALD BLUM AP Baseball Writer NEW YORK — New York Yankees outfielder Aaron Judge earned his second American League MVP award on Thursday. Judge was a unanimous pick for the first time, receiving all 30 first-place votes and 420 points in voting by the Baseball Writers’ Association of America. Kansas City shortstop Bobby Witt Jr. got all 30 second-place votes for 270 points, and Yankees outfielder Juan Soto was third with 21 third-place votes and 229 points. Dodgers star Shohei Ohtani won the National League MVP , his third MVP award, all of which have been unanimous. New York Mets shortstop Francisco Lindor was second with 263 points and Arizona second baseman Ketel Marte third with 229. Judge led the major leagues with 58 homers, 144 RBIs and 133 walks while hitting .322. Witt topped the big leagues with a .332 average, hitting 32 homers with 31 stolen bases and 109 RBIs. Soto batted .288 with 41 homers and 109 RBIs. When Judge won his first MVP award in 2022, he received 28 first-place votes while Ohtani got the other two. Judge had discussed the MVP award with Philadelphia’s Bryce Harper, the NL winner in 2015 and ’21. “I was telling him, ‘Man, I’m going to try to catch up to you with these MVPs here, man,’” Judge recalled. “He’d say, hopefully, he could stay a couple ahead of me, which I think he’ll do.” When Judge won his first MVP award in 2022, he received 28 first-place votes while Ohtani got the other two. He is the Yankees’ 22nd MVP winner, four more than any other team. Judge was hitting .207 with six homers and 18 RBIs through April, then batted .352 with 52 homers and 126 RBIs in 127 games. “March and April were not my friend this year.” Judge said. “Just keep putting in the work and things are going to change. You can’t mope. You can’t feel sorry for yourself. Especially in New York, nobody’s going to feel sorry for you. So you just got to go out there and put up the numbers?” Balloting was conducted before the postseason.
Prasar Bharati’s OTT Platform WAVES To Provide ‘Clean Family Entertainment’
NoneProve Your Allegations Against Me, Afe Babalola Challenges Farotimi
The home of the Sounders may now officially become the home for a country during the 2026 FIFA Men’s World Cup. FIFA announced an updated list of potential base camps for countries participating in the World Cup on Thursday that included the Sounders new training center at the former Longacres site in Renton. Adding the Sounders training center is an announcement that’s long been expected and was probably amplified by the visit last month from FIFA President Gianni Infantino to the area that also included a reception and tour of the facility. Seattle is set to host six matches during the tournament beginning in June 2026 – four in the group stage, one in the round of 32 and one in the round of 16. But cities can often serve as both host venues and base camps for various countries. For example, during the 2018 World Cup in Russia, the city of Sochi hosted matches while also being the base camp for Brazil and Poland at a couple of venues around the area. The Sounders facility was one of 26 new options added by FIFA that also included a couple of other potential sites in the Pacific Northwest. Across the state, Gonzaga University in Spokane is listed as a possible base camp. The Bulldogs’ Luger Field is a grass soccer stadium on the bank of the Spokane River. Another site in the region listed was Boise State University where the Broncos play at the Boas Soccer Complex. Any of the three Pacific Northwest locations would seem likely options for a country that ends up with the majority of its group stage games on the West Coast. Other cities are expected to be added as potential base camps for the 48 participating countries throughout 2025. Portland is not currently listed as a possible base camp but would seem a likely candidate with a few options in the area. The final decisions on what cities each country will call home for the tournament are expected a little over a year from now, shortly after the draw. The draw to set the groups and schedule for the tournament is expected to take place in December 2025.New 2025 laws hit hot topics from AI in movies to rapid-fire guns
American ski racer Mikaela Shiffrin was alert and being evaluated for injuries after crashing in her second run of a World Cup giant slalom race Saturday, doing a flip and sliding into the protective fencing. Shiffrin stayed down on the edge of the course for quite some time as the ski patrol attended to her. She was taken off the hill on a sled and waved to the cheering crowd. The U.S. Ski Team said she was taken to a medical clinic for evaluation. The 29-year-old Shiffrin was leading after the first run of the GS and charging after her 100th World Cup win. She was within sight of the finish line, five gates onto Killington’s steep finish pitch, when she lost the grip on her outside ski. She hit a gate and did a somersault before sliding into another gate. The fencing slowed her momentum as she came to an abrupt stop. Reigning Olympic GS champion Sara Hector of Sweden won in a combined time of 1 minute, 53.08 seconds. But her thoughts were instead with Shiffrin. “It’s just so sad, of course, to see Mikaela crash like that and skiing so well,” Hector said on the broadcast after her victory. “It breaks my heart and everybody else here.” The crash was a surprise, given that Shiffrin rarely records a “DNF,” or did not finish. In 275 World Cup starts, she has recorded a DNF only 19 times. The last time she did not finish in GS was January 2018. Saturday was shaping up to be a banner day for Shiffrin, who skied flawlessly in her first run and held a 0.32-second lead as she chased after her 100th World Cup win in front of a home crowd. Shiffrin grew up in both New Hampshire and Colorado and sharpened her skills at nearby Burke Mountain Academy. Shiffrin is driven not so much by wins but by making the perfect run. She has shattered so many records along the way. She passed Lindsey Vonn’s women’s mark of 82 World Cup victories on Jan. 24, 2023, during a giant slalom in Kronplatz, Italy. Nearly two months later, Shiffrin broke Swedish great Ingemar Stenmark’s Alpine mark for the most World Cup wins when she captured her 87th career race. Shiffrin has not suffered as many devastating injuries as many ski racers have. In her 14-year career, she has only had to rehab two injuries that happened on the hill: a torn medial collateral ligament and bone bruising in her right knee in December 2015 and a sprained MCL and tibiofibular ligament in her left knee after a downhill crash in January 2024. Neither knee injury required surgery and both times Shiffrin was back to racing within two months. To date, she has earned five overall World Cup titles, two Olympic gold medals — along with a silver — and seven world championships. Shiffrin’s signature event, the slalom, will be held Sunday. She has won six of the seven slalom races she’s entered at Killington. Meanwhile, fans hoping to see the world’s top female skiers compete next week in Mont-Tremblant, Quebec, are out of luck. That World Cup stop was canceled Saturday because the weather has not been cold enough to produce the necessary snow.After what they say has been months of refused visits with their four children in foster care, Kimberly and Jordan Joseph packed their bags and decided to walk more than 1,500 kilometres from “Prince Rupert, B.C.” to “Victoria.” The couple — both Dakelh (Carrier) — say they’re raising awareness about the lack of support for birth parents resulting in too many kids in the country’s child welfare system. During their 75-day journey, they met dozens of people with lived experience of the child welfare system, visited a number of Ministry of Children and Family Development (MCFD) offices, and earned the encouragement of hundreds of supporters. The Josephs live in Yekooche, a remote community of 87, northwest of “Fort St. James.” They said they weren’t just walking for Indigenous children and Youth — but every young person in foster care. On July 27, the couple set off, sending updates to their growing Facebook community. As the walk — and blisters — progressed, they alternated between walking and travelling by car, sometimes walking together or taking turns making the journey on foot while the other drove. The Josephs said they faced delays when MCFD repeatedly called to arrange visits with their kids, only to cancel after the couple had abandoned their walk to drive north. But they didn’t give up, and kept coming back to try and finish the walking journey. By late November, the Josephs had reached Sḵwx̱wú7mesh (Squamish). “It’s terrifying for a child to not understand why they can’t talk to their mom and their dad, or talk to their siblings,” said Kimberly during the stop on Nov. 25. Earlier that morning, the Josephs arrived holding hands, listening carefully to Kimberly’s smartphone. They were attending family court virtually — waiting to hear a judge’s response to their refusal for their children’s foster parents to continue caring for their boys. For Kimberly and Jordan, it was good news: the couple’s case will go to trial, she confirmed with a smile. There are now nearly 2,000 members of a Facebook group, “Walking For All Children in Ministry Care,” where the Josephs have given regular updates on their way. Until June 2023, the boys were in custody of Kimberly’s mother in “Kamloops,” but when she was no longer able to provide the care they needed, MCFD asked Kimberly if she would take them back. Though eager to be reunited with the children — of whom Jordan is a stepfather to three and biological father to one — it was not an easy process. The couple said they struggled with MCFD and Carrier Sekani Family Services (CSFS) for almost a year. While caring for their children, Kimberly said CSFS had received money through Jordan’s Principle — a legal rule ensuring First Nations children can access services and support in a timely manner — to deliver the couple diapers and baby formula from CSFS’s “Fort St. John” office to their remote home, where they had no access to transportation. “They didn’t do it for a month,” alleged Kimberly, who said despite phoning countless times, she had to enlist help from friends and family to get by. “Finally, we showed up at their office and they gave us [an entire month’s worth] of formula. They were like, ‘this is all yours, it’s just been sitting at the office.’” While Jordan was in counseling after the death of his grandfather, a therapist reported his behaviour to MCFD as “aggressive,” the couple alleged. “It was all false,” said Kimberly, who said she wishes the ministry had handled Jordan’s grief with more compassion. Eventually, they said, MCFD insisted that Kimberly move into a shelter, separate from Jordan — who had been residing in a tiny house. During this time, she was given a chance to prove she could care for her children, but said she was chastized by social workers, who allegedly told her she was neglectful and didn’t dress properly (“but I like to dress cozy,” she said). A 2021 report released by the MCFD states that 84 per cent of Indigenous children in foster care were there due to what they call “neglect.” “But neglect from whom?” said Cindy Blackstock, speaking to this issue at the recent Our Children Our Way National conference in “Vancouver.” Blackstock said she believes that child welfare laws push the blame onto the parents, when they should be asking, “What is the actual source of this risk?” she said. While in the women’s shelter, Kimberly said she experienced a health emergency that resulted in her needing to be hospitalized. When MCFD showed up alongside paramedics, she expressed to MCFD that she needed time to recuperate — knowing she would be closely watched and her poor health would make it impossible to comprehensively care for her children on her own. She said she got an ultimatum in return. “And now they’re saying I could have had the boys but I gave them up,” she said. Now that the couple’s children are back in foster care, Kimberly alleged there have been multiple occasions where MCFD has told them there are no funds available to allow them to visit their children, who are divided between foster families in “Prince Rupert” and “Prince George.” But Jordan said after being given a vehicle from Jordan’s aunt, he and Kimberly decided to visit their children using their own money. “It was awesome, we finally had our own transportation,” he said. When they phoned the MCFD office to ask for a visit, they repeated the same reason — “a lack of funds,” Jordan recalled. “We told them they don’t need funding — we are already down here, and we’ve got the money to do stuff with the boys.” An MCFD employee replied they’d look into scheduling a visit, but one week later — after multiple inquiries from Kimberly and Jordan — they said they were told there was no supervisor available to attend a visit. “I feel like whenever we ask for anything, our file gets thrown to the side and they say no,” said Kimberly. IndigiNews requested comment from MCFD, who said that although it could not comment on individual cases, it noted that “recruitment and retention are a continuous priority for the ministry and direct child and family service staffing numbers are stable.” “In the last two years, there has been a 17 per cent increase in staffing levels and staffing has been up year-over-year since the pandemic,” the statement reads. IndigiNews also reached out to Carrier Sekani Family Services, but did not receive a response by time of publication. For Kimberly and Jordan, their frustrations soon reached a tipping point. “We decided we wanted to walk,” Jordan said. The couple spent one week preparing — alerting police they’d be walking the road, telling friends and family, and creating a Facebook group. “It was a really nice send-off,” Kimberly recalled. “People came to see us and it was fun.” After just a day of walking, she was shocked to find roughly 500 people had joined their Facebook group by the time Kimberly regained cell service — and nearly 100 messages of encouragement. The number of people in the group soon grew to close to a couple thousand. “We were like, ‘No way!’ And then people were stopping for us along the way, giving us their food and drinks.” Originally, the couple’s plan was to walk just the 700-kilometre route from “Prince Rupert” to “Prince George” — because their children had been split up between homes in the two cities. But when the Josephs finally reached “Prince George,” they felt so encouraged by the public’s support that they decided to extend their journey to the province’s capital — an additional walk of more than 800 kilometres south. They packed up their car and began leapfrogging their way down — alternating between walking and driving in a shared effort. The couple said they’ve found the walk healing. “I’ve opened up a lot about my past,” said Kimberly, who herself grew up in the “child welfare” system. “I really don’t ever talk about my past, but I think walking has helped me quite a lot.” Jordan said the walk has been healing for him too. “Being close to nature, seeing all the animals and getting to connect with everything has been awesome,” he said. The couple weren’t as fond of the countless tiny frogs, grasshoppers, beetles. “We hate insects,” the couple said in unison. Kimberly says that — besides offering counselling — MCFD also wants her to take parenting and relationship courses. But she believes the structure of such programs are colonial. “There’s Indian time, right?” she said. “I’ve never liked Western structure.” During their walk, Kimberly and Jordan met with many people through social media who shared their own experiences with the child welfare system. “It’s a lot easier to open up to people like that,” Kimberley said, “than to have someone sitting across from you that you don’t really know, that doesn’t say anything back to you other than, ‘How do you feel about that?’” When she and Jordan spoke to IndigiNews in Sḵwx̱wú7mesh, it was actually their second time reaching the community. Back in October, the couple had walked as far as “Lions Bay” — 40 kilometres north of “Vancouver” — just when MCFD called about a visit they’d managed to arrange with their children. The Josephs headed back north. When they resumed their walk in November and finally reached “Vancouver,” the couple visited two local MCFD offices to ask staff what support systems they have for Indigenous mothers needing help. Kimberly recalls staff at both offices telling her she should make complaints through “the main office.” Later, after reaching “New Westminster,” the couple received another phone call from MCFD, alerting them to another visit the agency had arranged with their children. So for a second time, the couple returned north, only to learn the ministry had cancelled the visit due to “poor weather,” said Kimberly. “I keep telling them if you arrange a visit for us and we can show up, you have no excuse. You should be ready for us to receive our kids,” said Kimberly. On Nov. 30, the couple updated that they were finally being given an opportunity to visit their boys for a few hours. “I can’t wait to see our boys,” Jordan told the Facebook live. “Love and miss them so much.” With winter quickly approaching, Kimberly doesn’t think they’ll actually reach “Victoria” this year, though she hasn’t completely laid the idea to rest. In fact, she’s already planning next year’s walk. “We want to do it until something’s done for the foster children,” she said. With a pre-trial date being set, Kimberly and Jordan now want to focus their attention on preparing for their day in court, hoping to finally be reunited with their children. “Not all parents get to hug their children, not all parents get to play with them, wake up to them, go to sleep and tuck them in,” Kimberly said. As the couple ponders the next steps on their journey, Jordan added that “time is precious” for any parent. “We have to be watched every time we see ours,” he said. “So cherish every moment with your kids.”